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Ghrelin (GHRL) and its receptor (GHSR) are involved in various bioactivities. In this study, the complete cDNA and 5  ﬂanking
region of the duck GHRL (dGHRL) gene and a 3717bp fragment of the duck GHSR (dGHSR) gene were obtained. A total of
19, 8, 43, and 48SNPs identiﬁed in 2751, 1358, 3671, and 3567bp of the chicken GHRL (cGHRL), chicken GHSR (cGHSR),
dGHRL,a n ddGHSR genes, respectively. Both cGHRL and dGHRL were expressed predominantly in the proventriculus, whereas
the highest mRNA levels of cGHSR and dGHSR were detected in the breast muscle and pituitary. Association analysis showed that
C-2047G, A-2355C, and A-2220C of the cGHRL gene were signiﬁcantly associated with abdominal fat weight (AFW; P = .01),
crude protein content of leg muscle (CPCLM; P = .02), and CPCLM (P = .0009), respectively. C-1459T of the cGHSR gene
was also signiﬁcantly associated with CPCLM (P = .0004). C-729T of dGHRL and A3427T of dGHSR were both signiﬁcantly
associated with subcutaneous fat thickness (SFT; P = .04). It was indicated by this study that the GHRL and GHSR genes were
related to fat deposition in both chicken and duck.
Copyright © 2009 Q. Nie et al. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Small synthetic molecules termed Growth Hormone Sec-
retagogues (GHSs) act on the pituitary gland and the
hypothalamus to regulate growth hormone (GH) release.
The Growth Hormone Secretagogue Receptor (GHSR or
GHS-R),aGprotein-coupledreceptor,hasbeenclonedfrom
human and pig and is mainly expressed in the pituitary,
hypothalamus, and hippocampus [1]. In 1999, a novel 28-
amino acid gut-brain peptide named Ghrelin (GHRL) was
ﬁrst isolated from the mammalian stomach [2]. Similar to
the synthetic molecules of GHSs, GHRL proved to be an
endogenous ligand for GHSR and involved in GH secretion,
food intake, and energy homeostasis [2, 3]. Even though the
mature GHRL varies in structure among mammals, birds,
and ﬁsh, the n-octanoylation of the Ser-3 residue is highly
conserved and essential for biological activity [2, 4]. It is now
well known that GHRL interacts with GHSR to mediate a
variety of bioactivities through the neuroendocrine pathway.
The GHRL and GHSR genes are reportedly related to
obesity in human and mouse. Body mass index and body fat
were shown to be negatively correlated with plasma GHRL
levels [5–8]. Two polymorphisms, Arg51Gln and Leu72Met,
in the human GHRL gene were identiﬁed in obese subjects,
and Leu72Met was signiﬁcantly associated with body mass
index and fat mass in some human populations [9, 10].
In addition to these two nonsynonymous SNPs, two other
variations of Gln90Leu and a frameshift mutation (2bp
deletionatcodon34)werealsoreportedinthehumanGHRL
gene, and the 90Leu allele frequency was signiﬁcantly higher
in extremely obese children and adolescents (0.063) than
in normal-weight students [11]. A novel SNP, T3056C in
intron 2 of the GHRL gene, was signiﬁcantly associated with
the acylation of GHRL and some fatness traits, including
high body mass index, body weight, fat mass, and skinfold
thickness [12]. Among 11 SNPs identiﬁed in the 5  ﬂanking
region of the GHRL gene, SNP-501A > C was signiﬁcantly
associated with body mass index in human [13]. In mice, the
peripheral administration of GHRL was found to regulate
body weight, adiposity, and UCP mRNA expression [14].
It was also interesting that central administration of GHRL
enhanced rat fat ingestion [15].2 Journal of Biomedicine and Biotechnology
Until now, the research progress on the GHRL and GHSR
genes was achieved in chicken. The chicken GHRL (cGHRL)
gene cDNA was ﬁrst cloned by Kaiya et al. [16], and it
encoded a 116-amino acid GHRL precursor and a 26-amino
acid mature GHRL. The complete cGHRL gene comprised
ﬁveexonsandfourintrons.Theﬁrstexondidnotencodeany
amino acids, a characteristic that was conserved in mammals
[17, 18]. The cGHSR gene was composed of two exons
separated by an intron and encoded a normal GHSR with
seven transmembrane domains (TM1 to TM7); however, a
variant GHSR without TM6 due to a 48-bp deletion was
found [19]. A total of 19 and 37 SNPs were identiﬁed in
the cGHRL and cGHSR genes, respectively [20], and an 8-
bp indel in the 5  untranslated region (UTR) and some
SNPs of the cGHRL gene were related to chicken growth and
muscle ﬁber traits [21–23]. A 6-bp indel of the cGHSR gene
was signiﬁcantly linked with fat traits [21]. The duck GHRL
(dGHRL) gene cDNA was also cloned, and the encoded
dGHRL was highly similar to cGHRL [24]. Nevertheless, no
further studies on the dGHRL and duck GHSR (dGHSR)
g e n e sh a v eb e e nr e p o r t e d .
Fat deposition is signiﬁcant in both chicken and duck.
Most fat accumulates as abdominal fat in chicken but
as subcutaneous fat in duck; these characteristics make
the chicken and duck ideal for use in this study. RACE,
genome walking, real time PCR, and association analysis
were performed to characterize the GHRL and GHSR genes
and reveal their eﬀects on fat deposition in chicken and
duck.
2.MaterialsandMethods
2.1. Animals and Sample Preparation. A total of 411 birds
(219 males and 193 females) from 8 chicken populations
(POP1 to POP8) and 139 birds from 9 duck populations
(POP9 to POP17) were used in this study (Table 1). These
samples consisted of six chicken breeds, including Xinghua
(XH), White Recessive Rock (WRR), Taihe Silkies (TS),
Leghorn (LH), Lingnan Yellow (LY), Huiyang Beard (HB),
and an F2 full-sib hybrid population (XH&WRR) described
by Fang et al. [23],aswellasfourduckbreeds,SanshuiWhite
(SW), Peking (PK), Partridge (PT), and Lake (LK). Either
blood or live tissues were collected from these birds at 9
weeks of age for the purpose of sequence cloning, variation,
mRNA quantitative expression, cell culture, and marker trait
association analyses (Table 1).
The SW commercial population (POP14), including
100 ducks (52 males and 48 females), were slaughtered
at 90 days old, and body weights at hatch (g) and 90
days old (g), carcass weight (g), fat thickness under skin
(mm), fat width (mm), eviscerated weight (g), abdominal
fat pad weight (g), and abdominal fat pad ratio (%) were
recorded. All birds were raised in separate pens and fed
with commercial corn-soybean-based diets that met NRC
requirements. All chickens were collected from Guangdong
Wens Foodstuﬀ Corporation Ltd. (Guangdong, China), and
all ducks were provided by Guangdong Sanshui Lianke Duck
Farm (Guangdong, China).
Genomic DNA was extracted from EDTA-anticoagulated
blood. Total RNA was extracted from the isolated tissues
using an improved Trizol isolation method (Invitrogen,
California, USA) following the manufacturer’s instruc-
tions. One microgram of total RNA was used to obtain
cDNA by reverse transcription with use of the Rever
Tra Ace Transcriptase Kit (Toyobo, Japan) and random
hexamers.
2.2. Primers. Thirty-three primer pairs (PM1 to PM33)
were designed and consisted of PM1 to PM6 (6) for the
cGHRL gene, PM7 to PM10 (4) for the cGHSR gene,
PM11 for the chicken β-actin gene, PM12 to PM24 (13)
for the dGHRL g e n e ,P M 2 5t oP M 3 2( 8 )f o rt h edGHSR
gene, and PM33 for the duck β-actin gene (Table 2).
PM12 and PM26 were both genomic primers, each of
which consisting of three reverse primers and a random
forward primer supplied by the Genomic Walking Kit. PM14
was a primer pair for 3  RACE, and the remaining 30
primer pairs were gene-speciﬁc primers. The GENETOOL
software (http://www.biologysoft.com/)w a su s e dt od e s i g n
the primers based on reported sequences of the chicken
GHRL (GenBank AB075215), GHSR (GenBank AB095994),
and β-actin genes (GenBank NM 205518), as well as duck
GHRL (GenBank AY338466), GHSR (GenBank EU005225),
β-actin (GenBank EF667345), and goose GHRL (GenBank
AY338465). All primers were commercially synthesized
by Shanghai Biosune Biotechnology Co. Ltd. (Shanghai,
China).
2.3. PCR, PCR-RFLP, and Sequencing. PCR was performed
in 25μL reactions containing 50ng chicken genomic DNA,
1× PCR buﬀer, 12.5pmol primers, 100μMo fe a c hd N T P ,
1.5mM MgCl2,a n d1 . 0 UTaq D N Ap o l y m e r a s e( S a n g o n
Biological Engineering Technology Company, Shanghai,
China). PCR was run in a Mastercycler gradient (M. J.
Research Co. Ltd., USA) with the following procedure: 3
minutes at 94
◦C, followed by 35 cycles of 30 seconds at
94
◦C, 45 seconds at the annealing temperature (58–62
◦C)
and 1 minute at 72
◦C, and a ﬁnal extension of 5 minutes at
72
◦C. PCR products were checked for size and quality on 1%
agarose gels.
The PCR product of PM5 was sequenced for genotyping
of the A-2220C, A-2246G, A-2355C, C-2399del, C-2030T,
and C-2047G polymorphisms in the cGHRL gene. The PCR
product of the PM7 reaction was digested with Tat I with the
PCR-RFLP method for genotyping C-1896A in the cGHSR
gene. The PCR product of the PM8 reaction was digested
by Hin1 II with the PCR-RFLP method for genotyping the
C-1459T SNP in the cGHSR gene. The PCR product of the
PM9 reaction was digested with Tail I with the PCR-RFLP
method for genotyping the A-1022C SNP in the cGHSR
gene. The PCR product of the PM20 reaction was digested
with Csp6 I with the PCR-RFLP method for genotyping
the C-729T SNP in the dGHRL gene. The PCR product of
the PM22 reaction was digested with Tail I with the PCR-
RFLP method for genotyping the T985C SNP in the dGHRL
gene. The PCR product of the PM30 reaction was digested
with Csp6 I with the PCR-RFLP method for genotypingJournal of Biomedicine and Biotechnology 3
Table 1: Chicken and duck samples used in this study.
No. Species Population(1) Samples Blood/live tissues Purpose
POP1 Chicken XH 6 (3 ♂;3♀)
Blood for DNA GHRL and GHSR gene variation POP2 Chicken WRR 6 (3 ♂;3♀)
POP3 Chicken TS 6 (3 ♂;3♀)
POP4 Chicken LH 6 (3 ♂;3♀)
POP5 Chicken XH&WRR 373 (200 ♂; 173 ♀) Blood for DNA Association analysis
POP6 Chicken LY 6 (3 ♂;3♀) 18 tissues (2) Real time PCR
POP7 Chicken HY 6 (3 ♂;3♀)
POP8 Chicken LY 2 ♀ Subcutaneous and abdominal adipose tissues Cell culture
POP9 Duck SW 1 ♂ Blood for DNA and proventriculus tissue GHRL gene sequence cloning
POP10 Duck SW 6 (3 ♂;3♀)
Blood for DNA GHRL and GHSR gene variation POP11 Duck PK 6 (3 ♂;3♀)
POP12 Duck PT 6 (3 ♂;3♀)
POP13 Duck LK 6 (3 ♂;3♀)
POP14 Duck SW 100 (52 ♂;4 8♀) Blood for DNA Association analysis
POP15 Duck SW 6 (3 ♂;3♀) 18 tissues Real time PCR
POP16 Duck PT 6 (3 ♂;3♀)
POP17 Duck SW 2 ♀ Subcutaneous and abdominal adipose tissues Cell culture
(1)XH = Xinghua chicken, WRR = White Recessive Rock, TS = Taihe Silkies, LH = Leghorn, XH&WRR = an F2 population crossed by XH and WRR, LY =
Lingnan Yellow, HY = Huiyang Beard, SW = Sanshui White duck, PK = Peking duck, PT = Partridge duck, and LK = Lake duck.
(2) The 18 tissues used were pituitary, cerebrum, lung, abdominal fat, liver, testis, proventriculus, ovary, subcutaneous fat, spleen, kidney, oviduct, leg muscle,
uropygial gland, hypothalamus, glandularis, small intestine, cerebellum, heart and breast muscle.
the T404C SNP in the dGHSR gene. The PCR product of
the PM31 reaction was digested with Csp6 I with the PCR-
RFLPmethodforgenotypingtheA3427GSNPinthedGHSR
gene.Digestionproductsweredetectedbyagarosegel(1.5%)
electrophoresis, and genotypes were determined by speciﬁc
proﬁles (Supplementary Figure 1 in Supplementary Material
available on-line at doi: 10.1155/2009/567120).
2.4. RT-PCR and 3  RACE. Total RNA was extracted from
the proventriculus from an SW duck by the TRIzol reagent
(Invitrogen, Carlsbad, CA) following the manufacturer’s
instructions. A proventriculus cDNA library was prepared
using the SMART RACE cDNA ampliﬁcation kit (Clontech
Laboratories, Mountain View, CA). Primer-directed RT-
PCR and 3  rapid ampliﬁcation of cDNA ends (RACE)
were used to generate duck GHRL cDNAs, ampliﬁed
u s i n gp r i m e r sP 1t oP 3( Table 2). A cDNA library was
prepared using the SMART RACE cDNA ampliﬁcation
kit (Clontech Laboratories, Mountain View, CA). The 3 
ends of the cDNAs were ampliﬁed with a speciﬁc forward
primer and reverse random primers from the SMART
RACE cDNA ampliﬁcation kit following the manufacturer’s
instructions.
2.5. Genome Walking. To obtain the 5  ﬂanking region of
the duck GHRL and GHSR genes, genome walking was
performed using the Genome Walking Kit (TakaRa, Japan).
The duck genomic DNA was puriﬁed using the Genomic
DNA Puriﬁcation Kit (U-gene, China) and was then used for
genome walking. The genome walking procedure included
three reactions: the ﬁrst PCR reaction used the outer adaptor
primer AP1 from the kit and an outer gene-speciﬁc primer
PM12R1 (or PM26R1); the second reaction used primers
AP2 and PM26R2; the third reaction used primers AP3
and PM26R3. Each reaction was performed step-by-step
following the kit instructions. PCR products of the third
reaction were puriﬁed using the Gel Extraction Kit (U-gene,
China), cloned into the pGEM-T easy vector (Promega,
USA), and sequenced by Shanghai Biosune Biotechnology
C o .L t d .( S h a n g h a i ,C h i n a ) .
2.6. Quantitative Real Time PCR. T h em R N Al e v e l so f
GHRL and GHSR in 18 tissues of chickens and ducks were
determined by quantitative real time PCR with SYBR green
dye using β-actin as an internal positive control (IPC). The
15μL PCR mixture contained 1μL of cDNA, 7.5μMS u p e r
Mix (Toyobo, Japan), 10μM of each primer (PM6, PM10,
PM11, PM24, PM32, and PM33), and 6.0μLD E P CH 2O.
Real time PCR was run on an ABI 7500 (Applied Biosystems,
Foster City, CA, USA) using the following program: initial
denaturation at 95
◦C f o r4m i n u t e s ,t h e n4 0c y c l e so f
94
◦C for 30 seconds, 63
◦C for 30 seconds, and 72
◦Cf o r
45 seconds. Each sample was repeated three times and
the average mRNA level was obtained for further analysis.
Two random PCR products of PM6, PM10, PM11, PM24,
PM32, and PM33 were sequenced by Shanghai Biosune
Biotechnology Co. Ltd. (Shanghai, China) to conﬁrm that
speciﬁc fragments of the cGHRL, cGHSR,c h i c k e nβ-actin,
dGHRL, dGHSR,a n dd u c kβ-actin genes were obtained.
Quantitative values were obtained from the Ct values, which
were the inverse ratio relative to the starting PCR product.
The relative quantiﬁcation was obtained by 2−ΔCt in which4 Journal of Biomedicine and Biotechnology
Table 2: Descriptions of the 33 primers used in this study.
Gene Primer Forward/reverse Sequence (5  to 3 ) Annealing temp (◦C) Purpose
cGHRL
PM1 PM1F tgctgaaggaccgaaaacaaa 56 SNP identiﬁcation
PM1R gccttgacagatgccttagtg
PM2 PM2F aagaaagctggtaactgcactag 55 SNP identiﬁcation
PM2R ggtgggctggtggagtta
PM3 PM3F tgcgttctgctactctttttcat 63 SNP identiﬁcation
PM3R gggccaaggaggagtgtct
PM4 PM4F cggcagacactcctcctt 57 SNP identiﬁcation
PM4R gccatccttccaactgtgtatat
PM5 PM5F tatgcgttctgctactcttt 58 Genotyping by sequencing
PM5R tggaagcgatcactatacc
PM6 PM6F catacagcaacaaaaggatac 63 Real time PCR
PM6R tgtggttgtccttcagct
cGHSR
PM7 PM7F gtgggtcagggcatcaaactc 58 SNP identiﬁcation and PCR-RFLP
PM7R tcgagggctgctgaattttatg
PM8 PM8F ggctcttcctttttggtttgtct 60 SNP identiﬁcation and PCR-RFLP
PM8R tcgccctctctctgattcacct
PM9 PM9F tgatgccactggtctgagaat 58 Genotyping by PCR-RFLP
PM9R tatccagctgcccatgtaaat
PM10 PM10F tgggcgtcgagcatgagaat 63 Real time PCR
PM10R ccacgactagcatcttcacag
Chicken β-actin PM11 PM11F ccccaaagccaacagagaga 63 Real time PCR
PM11R ggtggtgaagctgtagcctctc
dGHRL
PM12
PM12F Genomic Walking Kit
According to the kit Genomic Walking PM12R1 ttccatcagttctagacgagt
PM12R2 tgtttgtccatactcttgatact
PM12R3 gcccctgctttatctgtatc
PM13 PM13F ccgcctggtgaagaaaac 56 RT-PCR
PM13R aagcctacacatccacctgcaat
PM14 PM14F gaggcaagctgaaggacaaccaca 54 3  RACE
PM14R 3  RACE Kit
PM15 PM15F gctggttttcccgtgtaattc 56 RT-PCR
PM15R tgtttgtccatactcttgatact
PM16 PM16F gctggttttcccgtgtaattc 54 Intron 1 ampliﬁcation
PM16R tgtttgtccatactcttgatact
PM17 PM17F tggtttggctggctctagt 56 Intron 2 ampliﬁcation
PM7R PM12R3
PM18 PM18F aaagcaggggcagaagat 57 Intron 3 ampliﬁcation
PM18R PM12R2
PM19 PM19F agggtcctggtccaaaaat 54 Intron 4 ampliﬁcation
PM19R PM12R1
PM20 PM20F cgcatggtagccttcacacac 56 SNP identiﬁcation and PCR-RFLP
PM20R agccgatgggttagcagagag
PM21 PM21F tcggctccatcagttgcagttat 56 SNP identiﬁcation
PM21R cggcgatgtatttttgctgttg
PM22 PM22F tccccacgacagagtagtttgag 56 SNP identiﬁcation and PCR-RFLP
PM22R gccttcccctgcttcctaa
PM23 PM23F atagcagcattttagaagtga 54 SNP identiﬁcation
PM23R ttgcctcagcttttcact
PM24 PM24F cgtgtaattcctctctgctaa 63 Real time PCR
PM24R cgatgtatttttgctgttgttJournal of Biomedicine and Biotechnology 5
Table 2: Continued.
Gene Primer Forward/reverse Sequence (5  to 3 ) Annealing temp (◦C) Purpose
dGHSR
PM25 PM25F cccctgagcaccaacgagt 56 Intron 1 ampliﬁcation
PM25R ggcaaccagcagagtatga
PM26
PM26F Genomic Walking Kit
According to the kit Genomic Walking PM26R1 cggaccgatgttctttctcttt
PM26R2 gacgggcaggaaaaagaagac
PM26R3 ggcccagaggatgaggatga
PM27 PM27F tggcgttctccgacctgctcat 57 SNP identiﬁcation
PM27R acacagaccctcagaaacac
PM28 PM28F cgggtggcttaaataacaacag 56 SNP identiﬁcation
PM28R tgccctttttcctcagtttctc
PM29 PM29F cggaccataattaaacacctgaa 56 SNP identiﬁcation
PM29R caggtagaagaggacaaaggaca
PM30 PM30F tggcgttctccgacctgctcat 56 Genotyping by PCR-RFLP
PM30R acacagaccctcagaaacac
PM31 PM31F gcaggttgtttagatatggct 56 Genotyping by PCR-RFLP
PM31R cgtgaaaaggcaaccagcagag
PM32 PM32F cccctgagcaccaacgagt 63 Real time PCR
PM32R ccaccacaactaacattttcaca
Duck β-actin PM33 PM33F acgccaacacggtgctg 63 Real time PCR
PM33R gggtccggattcatcatactc
ΔCt = Cttarget gene − CtIPC. The data are expressed as the
mean ± S.E. Statistics were analyzed by SAS Students t-test
that measures analysis of variance with a signiﬁcance level of
0.05.
2.7. Statistics Methods
2.7.1. Sequence BLAST, Prediction of Transcription Factors,
and Haplotypes. The homology of GHRL among human,
mouse, chicken, turkey, emu, goose, and duck was studied.
Identity percentages were obtained from amino acid BLAST
with the DNASTAR software (http://www.dnastar.com/).
The obtained sequences of GHRL and GHSR were aligned
with the Mega 3.1 software (http://www.megasoftware.net/).
The 798-bp 5  ﬂanking region of the dGHRL gene
obtained in this study was used to predict the potential
binding sites for transcription factors by an online ser-
vice (http://www.fruitﬂy.org/cgi-bin/seq tools/promoter.pl).
In the chicken F2 population (XH&WRR) and the duck
commercial population (SW), haplotypes were inferred
based on the genotype data with the PHASE 2.1 software
(http://en.wikipedia.org/wiki/Phase)[ 25].
2.7.2. Nucleotide Diversity (θ). To evaluate the nucleotide
diversity, the normalized numbers of SNPs (θ)w e r ec a l -
culated by dividing K, the number of observed nucleotide
changes, by the total sequence length in base pairs (L)a n d
correcting for the sample size (n) as described in [26], using
the following formula:
θ =
K
n−1
i=1 i−1L
. (1)
2.7.3. Marker-Trait Association Analysis. The eﬀects of 13
SNPs identiﬁed in this study on fatty traits were estimated
by marker-trait association analysis. These SNPs included six
in the cGHRL gene (C-2030T, C-2047G, A-2220C, A-2246G,
A-2355C, and C-2399del), three in the cGHSR gene (C-
1896A, C-1459T, and A-1022C), two in the dGHRL gene (C-
729T and T985C), and two in the dGHSR gene (T404C and
A3427G). Marker-trait association analysis was performed
using the SAS GLM procedure (SAS Institute, 1996) and the
geneticeﬀectswereanalyzedbya mixed procedureaccording
to the following model:
Y = μ+G+D +H +S+e,( 2 )
where Y is an observation on the trait, μ is the overall
population mean, G is the ﬁxed eﬀect of the genotype, D is
the random eﬀect of dam, H is the ﬁxed eﬀect of hatch, S is
the ﬁxed eﬀect of sex (male or female), and e is the residual
random error.
3. Results
3.1. Cloning the Full-Length cDNA of the dGHRL Gene. The
full-length cDNA of the dGHRL gene (835bp) was ampliﬁed
using primers PM13 to PM15. It comprised 115bp of the 5 
untranslatedregion(5   UTR),the351bpopenreadingframe
(ORF) encoding a 116-amino acid (aa) peptide, and 369bp
ofthe3  UTR(Figure 1)(GenBankEF613551).TheSWduck
GHRL precursor (116 aa) included a signal peptide (23 aa),
the mature GHRL (26 aa), and a long C-terminal peptide
(67 aa). Compared with the other reported mallard dGHRL
precursor sequence (NCBI accession number: AY338466),
there were some diﬀerent amino acids (W16R, G21A, A53T,6 Journal of Biomedicine and Biotechnology
Figure 1: cDNA and deduced amino acid sequence of the dGHRL gene. The arrowheads indicate the locations of introns. Polyadenylation
signal is boxed. The asterisk (∗) represents the putative stop codon (TGA). The nucleotide sequence is deposited in GenBank (EF613551).
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Figure 2: Alignment of GHRL sequences among 7 species. The mature peptides were boxed.
T59A, A64T, and G71S). The putative SW dGHRL precursor
showed identities of 88.8%, 72.4%, 69.8%, 71.6%, 37.9%,
and 37.1% with its counterparts of goose, chicken, turkey,
emu, mouse, and human, respectively (Figure 2). As far as
the mature peptides are concerned, however, dGHRL had
much higher homology with the other six species (92.3%,
65.4%,65.4%,69.2%,53.8%,and50.0%withgoose,chicken,
t u r k e y ,e m u ,m o u s e ,a n dh u m a n ,r e s p . )( Figure 2).
3.2. Genomic Organization of the dGHRL and dGHSR Genes.
The sequence ensemble generated with the PM12 to PM19
products gave rise to a 3670bp genomic fragment of the
dGHRL gene, which included 798bp of the 5  ﬂanking
region, 883bp of ﬁve exons (134, 137, 114, 109, and 389bp
for exon 1 to exon 5) and 1989bp of four introns (168, 469,
458, and 894bp for intron 1 to intron 4). Like other species,
thefourintronsofthedGHRLgeneallfollowedthe“GT-AG”
rule, and moreover, exon 1 did not encode any amino acids
(Supplementary Figure 2). The obtained dGHRL genomic
sequences were submitted to the NCBI database (GenBank
EF613552).
The 3717bp sequence of the dGHSR gene was deduced
by genomic walking (PM26), PCR ampliﬁcation (PM25)
and sequence ensemble with reported sequences (Genbank
EU005225). It comprised two incomplete exons (591 and
148bp for exon 1 and exon 2) and one intron (2978bp) that
followed the “GT-AG” intron rule (Supplementary Figure
2). The obtained dGHSR gene sequences were also submitted
to the NCBI database (GenBank FJ194548).
3.3. Online Prediction of Transcription Factor Binding Sites
in the dGHRL Gene. Online prediction of transcription
factor binding sites in the 5  ﬂanking region of the dGHRL
gene showed that a typical TATA box was present in 23bp
upstreamofthetranscriptionstartsite,andpotentialbinding
sites for some transcription factors were found, including
one AML-1a site (runt-factor AML-1), two cap 1 sites (cap
signal for transcription initiation), two CdxA 1 sites, three
GATA-1 sites (GATA-binding factor 1), as well as one Oct-1
site (octamer factor 1) (Figure 3).
3.4. SNPs and Nucleotide Diversity. A total of 19SNPs (10
transitions, 8 transversions, and 1 indel) and 1 polyA
polymorphism were identiﬁed in 2751bp of the 5  UTR
region of the cGHRL gene, while 8 SNPs (5 transitions and
3 transversions) were identiﬁed in 1358bp of the 5  UTR of
the cGHSR gene (Table 3). Forty-three SNPs (27 transitions,
15 transversions, and 1 triallelic SNP), 1 SSR, and 1 9-bpJournal of Biomedicine and Biotechnology 7
Figure 3: Online prediction of transcription factor binding sites and the TATA box in the 5  ﬂanking region of the dGHRL gene.
indel were identiﬁed in 3671bp of the dGHRL gene, while
48 SNPs (35 transitions and 13 transversions) and 5 indels
were found in 3567bp of the dGHSR gene (Table 3). Eleven
SNPs were located in the coding regions of the dGHRL gene,
but only four SNPs were nonsynonymous and led to amino
acid changes in the C-terminal extension peptide. For the
dGHSRgene,ho wev er ,nononsynon ymousSNP swer efound
within ﬁve SNPs in the coding regions (Table 3). A triallelic
SNP (GA/C at nt 1774) was observed in the coding region of
the dGHRL gene, which was related to three diﬀerent amino
acids (A/P/T at aa 59) (Table 3).
The average bps per SNP were 145, 170, 86, and 75 for
the cGHRL, cGHSR, dGHRL, and dGHSR genes, respectively.
The nucleotide diversities (θ) corrected for sample size were
1.83×10
−3,1.56×10
−3,3.10×10
−3,a n d3 .56×10
−3 for the
cGHRL, cGHSR, dGHRL, and dGHSR genes, respectively.
3.5. Tissue-Speciﬁc Expression of the cGHRL, cGHSR, dGHRL,
and dGHSR Genes. The highest mRNA level of the cGHRL
gene was found in the proventriculus and then the pituitary,
cerebrum, abdominal fat, subcutaneous fat, hypothalamus,
small intestine, heart, and breast muscle. The highest mRNA
levelofthedGHRLgenewasalsofoundintheproventriculus
and then the abdominal fat, testicles, subcutaneous fat,
uropygialgland,andbreastmuscle(Figure 4;Supplementary
Table 1).
The highest mRNA level of the cGHSR gene was
detected in the breast muscle and then the subcutaneous
fat, leg muscle, abdominal fat, heart, spleen, liver, uropygial
gland, cerebrum, proventriculus, pituitary, and testicles. The
highest mRNA level of the dGHSR gene was detected in
the pituitary and then the subcutaneous fat, hypothalamus,
small intestine, testis, cerebellum, and cerebrum, whereas
little mRNA was found in the other tissues (Figure 4;
Supplementary Table 1).
When the HB and LY chicken breeds were compared,
signiﬁcant diﬀerences in the GHRL mRNA levels were found
in the proventriculus, subcutaneous fat, lung, and kidney
(P<. 05), whereas signiﬁcant diﬀerences in the GHSR
mRNA levels were found in the hypothalamus and breast
muscle (P<. 05). When the PT duck and SW duck breeds
were compared, signiﬁcant diﬀerences in the GHRL mRNA
levels were found in the proventriculus and subcutaneous fat
(P<. 05), whereas no signiﬁcant diﬀerences in the GHSR
mRNA levels were found in any tissues (P>. 05) (Figure 4;
Supplementary Table 1).
3.6. Associations of SNPs with Fatty Traits in Chicken and
Duck. For the cGHRL gene, C-2047G and A-2355C were
found to be signiﬁcantly associated with abdominal fat
weight (AFW; P = .01 <. 05) and crude protein content
of leg muscle (CPCLM; P = .02 <. 05), and A-2220C
was signiﬁcantly associated with CPCLM (P = .0009 <
.01). In addition, haplotypes across six SNPs (C-2030T,
C-2047G, A-2220C, A-2246G, A-2355C, and C-2399del)
were signiﬁcantly associated with AFW (P = .04 <. 05),
abdominal fat ratio (AFR; P = .04 <. 05), and CPCLM
(P<. 0001). As far as the three genotypes of each locus
were concerned, CC of C-2047G, CC of A-2220C, and AA
of A-2355C had the highest values of association with AFW
and CPCLM, indicating that the advantageous alleles for fat
deposition were C-2047, A-2220, and A-2355 (Table 4). For
the cGHSR gene, C-1459T was shown to be signiﬁcantly
associated with CPCLM (P = .0004 <. 01). Individuals
with the CC genotype had the highest CPCLM association,
indicating that C rather than T was the dominant allele for
CPCLM (Table 4).
In duck, C-729T and haplotypes of C-729T and T985C
of the dGHRL gene were both signiﬁcantly associated with
subcutaneous fat thickness (SFT; P = .04 and .05, resp.).
Individuals with the CT genotype of C-729T had the highest
SFT. For the dGHSR gene, A3427G and haplotypes of T404C
and A3427G were both signiﬁcantly associated with SFT
(P = .04 and .05, resp.). Individuals with the TT genotype
of C3427T had the highest SFT, indicating that T rather than
C was the dominant allele for fat deposition (Table 4).
4. Discussion
4.1. Molecular Characterization of the GHRL and GHSR
Genes. The genomic organization of the GHRL and GHSR
g e n e sw a sc o n s e r v e di nc h i c k e na n dd u c k( S u p p l e m e n t a r y
Figure 2). The cDNAs of the cGHRL and cGHSR genes
were reported by Kaiya et al. [16] and Tanaka et al. [19],8 Journal of Biomedicine and Biotechnology
Table 3: SNPs identiﬁed in the cGHRL, cGHSR, dGHRL, and dGHSR genes.
Gene No. SNP1 Region Note (2,3,4) No. SNP Region Note (2,3,4)
cGHRL
1 C-495T 5  ﬂanking 19369777(2)Dde I (3) 11 A-2220C 5  ﬂanking 19371502
2 C-517T 5  ﬂanking 19369799 12 A-2246G 5  ﬂanking 19371528 Tas I
3 C-873G 5  ﬂanking 19370155 13 A-2355C 5  ﬂanking 19371637
4 T-1038C 5  ﬂanking 19370320 14 C-2399del 5  ﬂanking 19371681
5 C-1253T 5  ﬂanking 19370535 Hin1 II 15 G-2861T 5  ﬂanking 19372143
6 T-1562G 5  ﬂanking 19370844 16 G-3264C 5  ﬂanking 19372546
7 A-1589G 5  ﬂanking 19370871 17 C-3290T 5  ﬂanking 19372572 Tai I
8 G-1950A 5  ﬂanking 19371232 18 G-3321T 5  ﬂanking 19372603
9 C-2030T 5  ﬂanking 19371312 19 T-3324C 5  ﬂanking 19372606
10 C-2046G 5  ﬂanking 19371329
cGHSR
1 A-1907G 5  ﬂanking 18787994 5 T-1288C 5  ﬂanking 18789055
2 C-1896A 5  ﬂanking 18788005 Tat I 6 A-1022C 5  ﬂanking 18789321 Tail I
3 C-1608T 5  ﬂanking 18788293 7 T-892C 5  ﬂanking 18789762 Bsa JI
4 C-1459T 5  ﬂanking 18788442 Hin1 II 8 G-834C 5  ﬂanking 18789820 Hin6 I
dGHRL
1 G221A 5  ﬂanking 23 T1128C Exon 2
2 T256C 5  ﬂanking 24 T1145C Exon 2 G5 Syn(4), Csp6 I
3 T263C 5  ﬂanking 25 C1179G Exon 2 R17G, Msp I
4 G273T 5  ﬂanking 26 A1244T Intron 2
5 A276C 5  ﬂanking 27 T1278C Intron 2
6 A303G 5  ﬂanking 28 G1390A Intron 2
7 A342C 5  ﬂanking 29 A1756G Exon 3 T53A, Hin 6 I
8 T401C 5  ﬂanking Csp6 I 30 G1761A Exon 3 E54 Syn
9 C405T 5  ﬂanking 31 G1774A/C Exon 3 A59P/T
10 A532C 5  ﬂanking 32 A1789G Exon 3 T64A
11 A628G 5  ﬂanking 33 C1803T Exon 3 N68 Syn
12 C638T 5  ﬂanking 34 A1807G Exon 3 G70S
13 A645G 5  ﬂanking 35 A1943C Intron 3 HpyCH4IV
14 C686G 5  ﬂanking 36 C2070T Intron 3
15 C691A 5  ﬂanking 37 T2115C Intron 3 TailI
16 A736T 5  ﬂanking 38 C2179T Intron 3
17 C778A 5  ﬂanking 39 A2324G Exon 4 E89 Syn
18 C1028A Intron 1 40 G2345A Exon 4 T96 Syn
19 A1070G Intron 1 41 A2351G Exon 4 E98 Syn
20 A1108G Exon 2 42 G2409C Intron 4
21 A1118G Exon 2 43 T2509C Intron 4
22 A1117G Exon 2
dGHSR
1 C320T Exon 1 A Syn, Msp I(4) 25 C2815A Intron
2 T359C Exon 1 N Syn 26 C2843T Intron
3 G398C Exon 1 T Syn, Bsa JI 27 C2861T Intron
4 T404C Exon 1 Y Syn, Csp6 I 28 G2863C Intron
5 G548A Exon 1 T Syn 29 C2883T Intron
6 C779T Intron 30 T2906C Intron
7 T1364A Intron 31 C2939A Intron
8 C1437T Intron 32 T2958A Intron
9 T1456C Intron 33 G2993A Intron
10 T1469C Intron 34 G3001A IntronJournal of Biomedicine and Biotechnology 9
Table 3: Continued.
Gene No. SNP1 Region Note (2,3,4) No. SNP Region Note (2,3,4)
dGHSR
11 C1478T Intron 35 A3304G Intron
12 A2393T Intron 36 A3037G Intron
13 C2430T Intron 37 T3050G Intron
14 A2431G Intron 38 G3080A Intron
15 T2578C Intron 39 T3208A Intron Taa I
16 T2591A Intron Tail I 40 C3329T Intron Taa I
17 T2619A Intron 41 T3340A Intron
18 C2657T Intron 42 G3362A Intron
19 C2681T Intron 43 G3363A Intron
20 A2682G Intron 44 T3380C Intron
21 G2746A Intron 45 C3424T Intron Csp6 I
22 T2792C Intron 46 A3427G Intron
23 G2794T Intron 47 A3451G Intron
24 G2803A Intron 48 C3543T Intron
(1)The ﬁrst nucleotide of start codon was marked as +1, and the next upstream nucleotide was −1. SNP position was determined based on reported sequences
of GenBank EF613552 (dGHRL gene) and FJ194548 (dGHSR gene), respectively. (2)SNP position was determined according to the released chicken genomic
sequence (http://genome.ucsc.edu/). (3)Restriction enzyme was used for PCR-RFLP. (4)SNP caused a codon and amino acid change.
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Figure 4: Relative mRNA expression levels of the GHRL and GHSR genes in adult chicken and duck tissues. The vertical axis indicates the
2−Ct value (mean ± S.E.M., n = 6). Pituitary, Cerebrum, Lung, Abdominal fat, Liver, Testis, Gizzard, Subcutaneous fat, Spleen, Kidney, Leg
muscle, Uropygial gland, Hypothalamus, Small intestine, Cerebellum, Heart, Breast muscle, and Proventriculus are considered.
respectively. The genome sequences of the cGHRL and
cGHSR genes were also previously known. The reported
cGHRL and cGHSR genes were 2706 and 4121bp long,
respectively, and comprised ﬁve and two exons each [17,
19, 27]. From the cloning and sequencing performed in this
study, the dGHRL cDNA (GenBank EF613551) had a 351-bp
ORF that encodes a 116-aa precursor. The predicted mature
dGHRL was a 26-aa peptide, and only two amino acids were
diﬀerentfromcGHRL.Theﬁrstsevenaminoacids,including
a serine residue at position 3 (site of n-octanoylation), of
the mature dGHRL are identical to those of chicken, turkey,
goose, and emu (Figure 2)[ 17, 24].10 Journal of Biomedicine and Biotechnology
Table 4: Eﬀects of SNPs on fatty traits in chicken and duck.
Gene SNP Traits P-value Genotype and traits
cGHRL
C-2047G AFW .01 29.01±1.089a (C/C) 25.57±3.46b (C/G) 23.30±5.676b (G/G)
A-2220C CPCLM .0009 20.71±0.1892a (A/A) 20.03±0.319a (A/C) 22.47±0.7554B (C/C)
A-2355C CPCLM .0203 21.83±0.4864a (A/A) 20.75±0.228b (A/C) 20.58±0.1889b (C/C)
cGHSR C-1456T CPCLM .0004 67.77±4.598a (C/C) 66.88±1.097a (C/T) 63.40±0.7162B (T/T)
dGHRL C-729T SFT .0408 1.52±0.22a (T/T) 2.44±0.32b (C/T) 2.02±0.48ab (C/C)
dGHSR C-3427T SFT .0407 0.80±0.77a (C/C) 1.79±0.30b (C/T) 1.93±0.23b (T/T)
Note that only signiﬁcant associations are shown in this table. AFW = abdominal fat weight; CPCLM = crude protein content of leg muscle; SFT =
subcutaneous fat thickness. Values within a row without a common superscript letter diﬀer and values with superscript letters diﬀer signiﬁcantly (P<. 05 and
P<. 01 each). Genotypes of a and b mean they diﬀered signiﬁcantly (P<. 05) and genotypes of a and B mean they diﬀered great signiﬁcantly (P<. 01).
The obtained dGHRL gene sequence (GenBank
EF613552) also comprised ﬁve exons and four introns,
and the ﬁrst exon did not encode any amino acids. This
characteristic was conserved in chicken, turkey, human,
and rodent [16–18, 28, 29]. The obtained 3717 bp sequence
of the dGHSR gene (GenBank FJ194548) consisted of two
exons and one intron and encoded a 347-aa mature receptor
protein. All introns of the cGHRL, cGHSR, dGHRL, and
dGHSR genes followed the GT-AG rule, which is conserved
in eukaryotic genes.
Online prediction indicated that a typical TATA box and
a number of transcriptional factor binding sites (AML-1a,
cap 1, CdxA 1, GATA-1, and Oct-1) were present in the 5 
ﬂanking region of the dGHRL gene. These transcriptional
factor binding sites were also found in the GHRL gene
promoter regions of human and chicken [29, 30], and a
“TATATAA” sequence was reported to be located at the
cGHRL gene promoter [18]. GATA regulatory motifs were
ﬁrst found in the promoters of globulin and other erythroid-
speciﬁc genes [31]. AML-1 is also a key regulator of
hematopoiesis and plays an important role in development
of all hematopoietic lineages [32]. It is possible that dGHRL
gene expression in hematopoietic cells would be regulated
by GATA-1 and AML-1a. The transcription factor cap-1 is a
key factor of the cap-dependent translation initiation mech-
anism. Oct-1 is one of the transcription factors with a POU
homeodomain and is expressed in most tissues including
the brain [33]. Moreover, Oct-1 plays very important roles
in the transcriptional regulation of gonadotropin-releasing
hormone and aldolase C gene expression in the brain [34,
35]. CdxA is one of the vertebrate caudal proteins that play
important roles in establishment of the body plan during
early development [36]. These transcription factor binding
sites in the putative promoter region might aﬀect dGHRL
gene expression.
The GHRL and GHSR genes were found to be more
variable in poultry than in mammals. As indicated by this
study, the SNP densities were 145, 170, 86, and 75bp per
SNP for the cGHRL (2751bp/19 SNP), cGHSR (1358/8),
dGHRL (3671/43), and dGHSR (3567/48) genes, respectively
(Table 3). In humans, a total of 11 SNPs were found in
1657bp of GHRL gene with an SNP density of 1 SNP/151bp
[13]. The reported density for the human GHSR gene (5
SNP of 1101bp) was 220bp per SNP [37]. Based on the
dbSNP data (http://www.ncbi.nlm.nih.gov), a total of 8 and
32 SNPs were reported in 2922 and 6494bp of the mouse
GHRL and GHSR genes, with estimated densities of 365
and 203bp per SNP, respectively. It was indicated that the
higher variations of the GHRL and GHSR genes were found
in chicken and duck compared with those of human and
mouse. Moreover, as far as these two species were concerned,
higher SNP densities were found in duck compared to
chicken, as the nucleotide diversity of the dGHRL (3.10 ×
10
−3)a n ddGHSR (3.56 × 10
−3) genes were much higher
than those of cGHRL (1.83×10
−3)a n dcGHSR (1.56×10
−3).
Our recent study on the chicken and duck THRSP α genes
also showed higher variations in the duck genome (data not
shown).
4.2. Eﬀects of the GHRL and GHSR Genes on Fat Depo-
sition. As indicated in this study, the GHRL and GHSR
genes were associated with fatness traits in chicken and
duck, which is consistent with some previous studies in
humans. Many studies showed associations of the GHRL
gene with adiposity [10–12, 38] and Type 2 diabetes [39]
in humans. Additionally, some polymorphisms in the GHSR
gene were found to be associated with obesity, bulimia
nervosa, and pharmacological abnormalities in humans [40–
43]. In chickens, the association of cGHRL polymorphisms
with growth traits has been reported [22, 23]. Moreover,
signiﬁcantassociationofthecGHSRgenewithseveralfatness
traits was reported by a recent study [21]. In this study, the
GHRL and GHSR genes were found to be associated with
several fatness traits like AFW, CPCLM, and SFT in both
chicken and duck.
Analysis of mRNA levels also showed the eﬀects of
the GHRL and GHSR genes on fat deposition in poultry.
Even though the GHRL gene was predominantly expressed
in the proventriculus, high mRNA levels of the GHRL
and GHSR genes were detected in subcutaneous fat and
abdominal fat in both chicken and duck (Figure 4). This
suggests that both GHRL and GHSR genes may be involved
in fat mobilization in poultry. Moreover, much higher GHRL
mRNA levels were found in LY (2.07 ± 0.06) rather than
HB (0.07 ± 0.05) chickens; higher levels were found in
SW (0.78 ± 0.01) compared to those in PT (0.13 ± 0.01)
ducks (Supplementary Table 1). SW ducks and LY chickens
are two fast-growing commercial breeds with higher fat
contents compared with those of the other two native breeds
of PT ducks and HB chickens. The higher GHRL mRNAJournal of Biomedicine and Biotechnology 11
in higher-fat breeds suggested that GHRL was probably
advantageous for fat deposition in poultry.
5. Conclusion
From these investigations, the variations and expression
patterns of the cGHRL, cGHSR, dGHRL, and dGHSR genes
were characterized, and some SNPs of these genes were
related to fatty traits.
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